54 related articles for article (PubMed ID: 10754292)
1. Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination.
Zang YC; Hong J; Rivera VM; Killian J; Zhang JZ
J Immunol; 2000 Apr; 164(8):4011-7. PubMed ID: 10754292
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal analysis of the T-cell receptor (TCR)-VA and -VB repertoire in CD8+ T cells from individuals immunized with recombinant hepatitis B surface antigen.
Höhn H; Neukirch C; Freitag K; Necker A; Hitzler W; Seliger B; Maeurer MJ
Clin Exp Immunol; 2002 Aug; 129(2):309-17. PubMed ID: 12165088
[TBL] [Abstract][Full Text] [Related]
3. T-cell receptor BV gene usage in colorectal carcinoma patients immunised with recombinant Ep-CAM protein or anti-idiotypic antibody.
Mosolits S; Markovic K; Fagerberg J; Frödin JE; Rezvany MR; Kiaii S; Mellstedt H; Jeddi-Tehrani M
Cancer Immunol Immunother; 2005 Jun; 54(6):557-70. PubMed ID: 15570423
[TBL] [Abstract][Full Text] [Related]
4. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone.
Hemmer B; Fleckenstein BT; Vergelli M; Jung G; McFarland H; Martin R; Wiesmüller KH
J Exp Med; 1997 May; 185(9):1651-9. PubMed ID: 9151902
[TBL] [Abstract][Full Text] [Related]
5. Generation of T cell clones binding F(ab')2 fragments of the idiotypic immunoglobulin in patients with monoclonal gammopathy.
Osterborg A; Masucci M; Bergenbrant S; Holm G; Lefvert AK; Mellstedt H
Cancer Immunol Immunother; 1991; 34(3):157-62. PubMed ID: 1756532
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Antigen-Specific Immunotherapies for the Treatment of Multiple Sclerosis.
Kammona O; Kiparissides C
Brain Sci; 2020 May; 10(6):. PubMed ID: 32486045
[TBL] [Abstract][Full Text] [Related]
7. Immune Response Regulation by Antigen Receptors' Clone-Specific Nonself Parts.
Lemke H
Front Immunol; 2018; 9():1471. PubMed ID: 30034389
[TBL] [Abstract][Full Text] [Related]
8. A Possible Role for Idiotype/Anti-idiotype B-T Cell Interactions in Maintaining Immune Memory.
Seledtsov VI; Seledtsova GV
Front Immunol; 2017; 8():409. PubMed ID: 28428787
[TBL] [Abstract][Full Text] [Related]
9. The mechanisms and applications of T cell vaccination for autoimmune diseases: a comprehensive review.
Huang X; Wu H; Lu Q
Clin Rev Allergy Immunol; 2014 Oct; 47(2):219-33. PubMed ID: 25096807
[TBL] [Abstract][Full Text] [Related]
10. Conservation of pathogenic TCR homology across class II restrictions in anti-ribonucleoprotein autoimmunity: extended efficacy of T cell vaccine therapy.
Zang Y; Martinez L; Fernandez I; Pignac-Kobinger J; Greidinger EL
J Immunol; 2014 May; 192(9):4093-102. PubMed ID: 24670800
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis.
Thomas R
Arthritis Res Ther; 2013 Feb; 15(1):204. PubMed ID: 23374912
[TBL] [Abstract][Full Text] [Related]
12. T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial.
Karussis D; Shor H; Yachnin J; Lanxner N; Amiel M; Baruch K; Keren-Zur Y; Haviv O; Filippi M; Petrou P; Hajag S; Vourka-Karussis U; Vaknin-Dembinsky A; Khoury S; Abramsky O; Atlan H; Cohen IR; Abulafia-Lapid R
PLoS One; 2012; 7(12):e50478. PubMed ID: 23272061
[TBL] [Abstract][Full Text] [Related]
13. Autologous T-cell vaccination for multiple sclerosis: a perspective on progress.
Vandenbark AA; Abulafia-Lapid R
BioDrugs; 2008; 22(4):265-73. PubMed ID: 18611069
[TBL] [Abstract][Full Text] [Related]
14. Vaccines for multiple sclerosis: progress to date.
Correale J; Farez M; Gilmore W
CNS Drugs; 2008; 22(3):175-98. PubMed ID: 18278975
[TBL] [Abstract][Full Text] [Related]
15. [Update on pathophysiologic and immunotherapeutic approaches for the treatment of multiple sclerosis].
Kleinschnitz C; Meuth SG; Kieseier BC; Wiendl H
Nervenarzt; 2007 Aug; 78(8):883-911. PubMed ID: 17551708
[TBL] [Abstract][Full Text] [Related]
16. CD4+ regulatory T cell responses induced by T cell vaccination in patients with multiple sclerosis.
Hong J; Zang YC; Nie H; Zhang JZ
Proc Natl Acad Sci U S A; 2006 Mar; 103(13):5024-9. PubMed ID: 16547138
[TBL] [Abstract][Full Text] [Related]
17. Homeostatic control of immunity by TCR peptide-specific Tregs.
Kumar V
J Clin Invest; 2004 Nov; 114(9):1222-6. PubMed ID: 15520851
[TBL] [Abstract][Full Text] [Related]
18. Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus.
Mandel M; Gurevich M; Pauzner R; Kaminski N; Achiron A
Clin Exp Immunol; 2004 Oct; 138(1):164-70. PubMed ID: 15373920
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.
Hohlfeld R; Wekerle H
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14599-606. PubMed ID: 15306684
[TBL] [Abstract][Full Text] [Related]
20. Autoreactive responses to an environmental factor. 2. Phthalate-induced anti-DNA specificity is downregulated by autoreactive cytotoxic T cells.
Lim SY; Ghosh SK
Immunology; 2004 May; 112(1):94-104. PubMed ID: 15096189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
